TCL Archive In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction August 21, 1981
TCL Archive Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib June 27, 2014
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
